Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer

Published:2019-05-01 Issue:5 Volume:5 Page:681
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Palma David A.¹²,Nguyen Timothy K.¹³,Louie Alexander V.¹²³,Malthaner Richard⁴,Fortin Dalilah⁴,Rodrigues George B.¹²,Yaremko Brian¹²,Laba Joanna¹²,Kwan Keith⁵,Gaede Stewart²⁶⁷,Lee Ting²⁶,Ward Aaron²⁶,Warner Andrew¹,Inculet Richard⁴

Affiliation:

1. Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada

2. Department of Oncology, Western University, London, Ontario, Canada

3. Currently with Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

4. Department of Surgery, Division of Thoracic Surgery, London Health Sciences Centre, London, Ontario, Canada

5. Department of Pathology, Western University, London, Ontario, Canada

6. Department of Medical Biophysics, Western University, London, Ontario, Canada

7. Department of Physics and Engineering, Western University, London, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

http:///jamaoncology/article-pdf/5/5/681/17575141/jamaoncology_palma_2019_oi_180121.pdf

Reference34 articles.

1. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.;Senthi;Lancet Oncol,2012

2. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.;Fakiris;Int J Radiat Oncol Biol Phys,2009

3. Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG Oncology RTOG 0618 Trial.;Timmerman;JAMA Oncol,2018

4. Long-term results of stereotactic body radiation therapy in medically inoperable stage I non–small cell lung cancer.;Timmerman;JAMA Oncol,2018

5. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.;Chang;Lancet Oncol,2015

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moving towards single fraction peripheral lung stereotactic body radiation therapy: patient care during and after the global COVID-19 pandemic;Lung Cancer Management;2024-07-03

2. Delta radiomics to track radiation response in lung tumors receiving stereotactic magnetic resonance-guided radiotherapy;Physics and Imaging in Radiation Oncology;2024-07

3. Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: a real-world multicenter retrospective study;Cancer Immunology, Immunotherapy;2024-05-07

4. Sub-lobar resections for peripheral non-small cell lung cancer measuring ≤ 2 cm: Insights from recent clinical trials;Radiotherapy and Oncology;2024-03

5. Impactos das terapias neoadjuvantes no câncer de pulmão de não pequenas células: uma revisão de literatura;Cuadernos de Educación y Desarrollo;2024-01-10